{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:29:03Z","timestamp":1769646543401,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) is an intricate metabolic disorder often accompanied by low-grade inflammation. This study aimed to investigate the relationship between the monocyte-to-lymphocyte ratio (MLR) and diabetic peripheral neuropathy (DPN) in patients with T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A total of 236 individuals diagnosed with T2DM participated in the research. Clinical parameters were assessed, including the Toronto Clinical Neuropathy Score (TCNS), Compound Muscle Action Potential (CMAP), Sensory Nerve Action Potential (SNAP), nerve conduction velocity (NCV), complete blood count, biochemical markers, and inflammatory indicators. These parameters were analyzed and compared, followed by logistic regression and receiver operating characteristic (ROC) curve analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The findings demonstrated that patients with DPN were generally older and had higher MLR levels and glycated hemoglobin levels, lower high-density lipoprotein cholesterol(HDL-C), longer disease duration, and higher FPG compared to patients without DPN. Additionally, CMAP and SNAP of median nerve (MN), ulnar nerve(UN), peroneal nerve (PN), and tibial nerve (TN) were significantly lower in the higher MLR group than in the higher MLR group(\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). ROC analysis indicated that MLR had an area under the curve (AUC) of 0.625, suggesting a limited discriminative ability to identify DPN.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study underscores the potential ability of MLR as a predictive biomarker for DPN in patients with T2DM, emphasizing the important role of inflammation in the development of this condition. But it has a low performance for DPN diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-025-02129-2","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T10:45:38Z","timestamp":1766745938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monocyte-to-lymphocyte ratio as an inflammatory biomarker for predicting diabetic peripheral neuropathy in type 2 diabetes mellitus patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoyao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"1","key":"2129_CR1","first-page":"1","volume":"1","author":"RA DeFronzo","year":"2015","unstructured":"DeFronzo RA, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. Nat Reviews Disease Primers. 2015;1(1):1\u201322.","journal-title":"Nat Reviews Disease Primers"},{"issue":"2","key":"2129_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1570161117666190502103733","volume":"18","author":"C Faselis","year":"2020","unstructured":"Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):117\u201324.","journal-title":"Curr Vasc Pharmacol"},{"key":"2129_CR3","doi-asserted-by":"publisher","first-page":"27571","DOI":"10.2340\/actadv.v104.27571","volume":"104","author":"SS Ertekin","year":"2024","unstructured":"Ertekin SS, Mangas C, Riquelme-Mc Loughlin C, et al. Prognostic value of the Neutrophil-to-lymphocyte ratio, Platelet-to- lymphocyte ratio and Monocyte-to-lymphocyte ratio in melanoma patients: A cohort study. Acta Derm Venereol. 2024;104:27571.","journal-title":"Acta Derm Venereol"},{"issue":"Suppl 1","key":"2129_CR4","first-page":"S11","volume":"40","author":"D Care","year":"2017","unstructured":"Care D. Classification and diagnosis of diabetes[J]. Diabetes Care. 2017;40(Suppl 1):S11\u201324.","journal-title":"Diabetes Care"},{"issue":"6","key":"2129_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521\u201334.","journal-title":"Lancet Neurol"},{"key":"2129_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/dmrr.2239","volume":"28","author":"S Tesfaye","year":"2012","unstructured":"Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy[J]. Diab\/Metab Res Rev. 2012;28:8\u201314.","journal-title":"Diab\/Metab Res Rev"},{"issue":"7","key":"2129_CR7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/dmrr.1226","volume":"27","author":"PJ Dyck","year":"2011","unstructured":"Dyck PJ, Albers JW, Andersen H, et al. Diabetic polyneuropathies: update on research Definition, diagnostic criteria and Estimation of severity. Diab\/Metab Res Rev. 2011;27(7):620\u20138.","journal-title":"Diab\/Metab Res Rev"},{"issue":"19","key":"2129_CR8","doi-asserted-by":"publisher","first-page":"10835","DOI":"10.3390\/ijms221910835","volume":"22","author":"P Baum","year":"2021","unstructured":"Baum P, et al. Inflammatory mechanisms in the pathophysiology of diabetic peripheral neuropathy (DN)\u2014new aspects. Int J Mol Sci. 2021;22(19):10835.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2129_CR9","doi-asserted-by":"publisher","first-page":"e14477","DOI":"10.1111\/cns.14477","volume":"30","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Chen Y, Li K, Liu S, Pang C, Gao L, Deng B. How inflammation dictates diabetic peripheral neuropathy: an enlightening review. CNS Neurosci Ther. 2024;30(4):e14477.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"2129_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11892-016-0727-5","volume":"16","author":"R Pop-Busui","year":"2016","unstructured":"Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman EL. Inflammation as a therapeutic target for diabetic neuropathies. Curr Diab Rep. 2016;16(3):29.","journal-title":"Curr Diab Rep"},{"issue":"3","key":"2129_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s12020-014-0437-1","volume":"48","author":"F Barutta","year":"2015","unstructured":"Barutta F, Bruno G, Grimaldi S, et al. Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment[J]. Endocrine. 2015;48(3):730\u201342.","journal-title":"Endocrine"},{"issue":"5","key":"2129_CR12","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/jdi.12794","volume":"9","author":"HY Jin","year":"2018","unstructured":"Jin HY, Park TS. Role of inflammatory biomarkers in diabetic peripheral neuropathy. J Diabetes Invest. 2018;9(5):1016.","journal-title":"J Diabetes Invest"},{"issue":"18","key":"2129_CR13","doi-asserted-by":"publisher","first-page":"10641","DOI":"10.3390\/ijms231810641","volume":"23","author":"F Vieceli Dalla Sega","year":"2022","unstructured":"Vieceli Dalla Sega F, Cimaglia P, Manfrini M, et al. Circulating biomarkers of endothelial dysfunction and inflammation in predicting clinical outcomes in diabetic patients with critical limb ischemia. Int J Mol Sci. 2022;23(18):10641.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2129_CR14","doi-asserted-by":"publisher","first-page":"13136","DOI":"10.1038\/s41598-023-40429-6","volume":"13","author":"C Qiu","year":"2023","unstructured":"Qiu C, Liu S, Li X, et al. Prognostic value of monocyte-to-lymphocyte ratio for 90-day all-cause mortality in type 2 diabetes mellitus patients with chronic kidney disease. Sci Rep. 2023;13(1):13136.","journal-title":"Sci Rep"},{"issue":"3","key":"2129_CR15","doi-asserted-by":"publisher","first-page":"BSR20180172","DOI":"10.1042\/BSR20180172","volume":"38","author":"J Liu","year":"2018","unstructured":"Liu J, Liu X, Li Y, et al. The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis. Biosci Rep. 2018;38(3):BSR20180172.","journal-title":"Biosci Rep"},{"issue":"1","key":"2129_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12902-024-01637-x","volume":"24","author":"CHEN Hai","year":"2024","unstructured":"Hai CHEN. The association between the neutrophil-to-lymphocyte ratio and type 2 diabetes mellitus: a cross-sectional study. BMC Endocr Disorders. 2024;24(1):107.","journal-title":"BMC Endocr Disorders"},{"issue":"8","key":"2129_CR17","doi-asserted-by":"publisher","first-page":"10009","DOI":"10.3390\/ijerph120810009","volume":"12","author":"S Yue","year":"2015","unstructured":"Yue S, Zhang J, Wu J, et al. Use of the Monocyte-to-Lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health. 2015;12(8):10009\u201319.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"2129_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10549-023-06979-z","volume":"200","author":"F Pivatto J\u00fanior","year":"2023","unstructured":"Pivatto J\u00fanior F, Santos \u00c2BS, Englert EF, et al. Monocyte-to-lymphocyte ratio as predictor of cancer therapy-related cardiotoxicity in patients with breast cancer: a pilot cohort study. Breast Cancer Res Treat. 2023;200(3):355\u201362.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"2129_CR19","doi-asserted-by":"publisher","first-page":"300060523120446","DOI":"10.1177\/03000605231204469","volume":"51","author":"M Vakhshoori","year":"2023","unstructured":"Vakhshoori M, Nemati S, Sabouhi S, et al. Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: a systematic review and meta-analysis. J Int Med Res. 2023;51(10):3000605231204469.","journal-title":"J Int Med Res"},{"key":"2129_CR20","doi-asserted-by":"publisher","unstructured":"Li Z, Jian Y, Deng C, et al. Association between monocyte-lymphocyte ratio and diabetic peripheral neuropathy in the US populations: a population-based study. BMC Neurol. 2025. PREPRINT (Version 1) available at Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-6637207\/v1.","DOI":"10.21203\/rs.3.rs-6637207\/v1"},{"issue":"1","key":"2129_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy[J]. Nat Reviews Disease Primers. 2019;5(1):41.","journal-title":"Nat Reviews Disease Primers"},{"issue":"5","key":"2129_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ana.410190504","volume":"19","author":"PJ Dyck","year":"1986","unstructured":"Dyck PJ, Karnes JL, O\u2019Brien P, Okazaki H, Lais A, Engelstad J. The Spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol. 1986;19(5):440\u20139.","journal-title":"Ann Neurol"},{"issue":"4","key":"2129_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.dsx.2018.03.026","volume":"12","author":"M Najafi","year":"2018","unstructured":"Najafi M, Hasanzadeh G, Hadian MR, et al. Electrophysiological measurements of diabetic peripheral neuropathy: A systematic review. Diabetes Metabolic Syndrome: Clin Res Reviews. 2018;12(4):591\u2013600.","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"issue":"4","key":"2129_CR24","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/ijms19040942","volume":"19","author":"A R\u00fcbsam","year":"2018","unstructured":"R\u00fcbsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy[J]. Int J Mol Sci. 2018;19(4):942.","journal-title":"Int J Mol Sci"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02129-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02129-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02129-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:29:50Z","timestamp":1769599790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-025-02129-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2129"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02129-2","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the ethical standards of the Declaration of Helsinki. Approval for the research protocol was obtained from the Medical Ethics Committee of Jiangxi Provincial People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}